<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>04</Month>
        <Day>16</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A review on the association between inflammatory markers and micronutrients in Covid-19 Patients with infection severity and T2DM</title>
    <FirstPage>1</FirstPage>
    <LastPage>16</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Reyhaneh</FirstName>
        <LastName>Sowti</LastName>
        <affiliation locale="en_US">Clinical Research Development Unit, Imam Reza General Hospital, Tabriz University of Medical Sciences,  Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farzad</FirstName>
        <LastName>Najafipour</LastName>
        <affiliation locale="en_US">Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sevil</FirstName>
        <LastName>Ghaffarzadeh Rad</LastName>
        <affiliation locale="en_US">Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hakimeh</FirstName>
        <LastName>Ghorbani</LastName>
        <affiliation locale="en_US">Department of Medical Biotechnology, Zanjan University of Medical Sciences, Zanjan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Halimeh</FirstName>
        <LastName>Amirazad</LastName>
        <affiliation locale="en_US">Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>04</Month>
        <Day>12</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The management of treatment strategies in COVID-19 is critical, especially in patients with type 2 diabetes. Non-enzymatic glycation of transmembrane protease serine 2 and angiotensin-converting enzyme 2 during COVID-19 in patients with diabetes may exacerbate immune dysregulation and inflammation. Elevated inflammatory cytokines such as IL-1, IL-2, IL-6, IL-7, and IL-10, tumor necrosis factor-&#x3B1;, interferon-&#x3B3;, granulocyte-macrophage colony-stimulating factor, and monocyte chemoattractant protein-1 have been observed in COVID-19 patients. This review aims to assess the relationship between inflammatory markers, including C-reactive protein, and micronutrients (vitamins D and C, zinc, and copper) with the severity of COVID-19 infection in patients with type 2 diabetes. A narrative review was conducted through a comprehensive literature search of English-language articles published between 2000 and 2025. The databases searched included PubMed, Scopus, the ISI Web of Science, Cochrane, and Embase. Search terms included COVID-19, infections, type 2 diabetes mellitus, interleukins, and micronutrients. English-language scientific articles, systematic reviews, and meta-analyses were included, while studies lacking sufficient information, letters, comments, and editorials were excluded. Evidence suggests that immune-boosting components such as proteins, vitamins, and minerals can enhance immunity to infections. Vitamins D and C, zinc, and copper play supportive roles in immune function, potentially modulating the inflammatory response in COVID-19 patients with type 2 diabetes. High levels of inflammatory cytokines correlate with increased disease severity in this population. Understanding the interplay between inflammatory markers and micronutrients may guide improved therapeutic strategies for managing COVID-19 in diabetic patients. Further research is warranted to clarify these relationships and optimize clinical outcomes.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4416</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4416/2327</pdf_url>
  </Article>
</Articles>
